Network origin in Bradford Goodwin first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.
154
| Subsidiary | Biotechnology | 154 |
| Private Company | Biotechnology | 30 | |
CoTherix, Inc.
 CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA.
16
| Subsidiary | Pharmaceuticals: Major | 16 |
| Extinct | Pharmaceuticals: Major | 16 | |
Abbott Biotherapeutics Corp.
 Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA.
13
| Extinct | Pharmaceuticals: Major | 13 |
Novacea, Inc.
 Novacea, Inc. Pharmaceuticals: MajorHealth Technology Novacea, Inc. is a privately held biopharmaceutical company focused on licensing, developing and commercializing novel agents to revolutionize the treatment of cancer. Novacea’s in-licensed product portfolio features three clinical stage oncology therapeutics. The Company has two products which are anticipated to commence Phase 3 clinical trials in 2006, DN-101 and vinorelbine oral. Banoxantrone (AQ4N) is in Phase 1/2 clinical trials. It is located in South San Francisco, CA.
11
| Extinct | Pharmaceuticals: Major | 11 |
R&D Logic, Inc.
 R&D Logic, Inc. Packaged SoftwareTechnology Services R&D Logic, Inc. provides cloud-based portfolio and corporate performance management solutions. Its platform enables finance and non-finance users to plan, monitor, analyze, and manage performance across their research and development portfolio and corporation. The firm's services include support, training, and integration. The company was founded by Wanda Ionescu and is headquartered in San Mateo, CA.
3
| Private Company | Packaged Software | 3 |
Collabra Pharma, Inc.
3
| Private Company | 3 | |
CharlestonPharma LLC
 CharlestonPharma LLC Medical SpecialtiesHealth Technology CharlestonPharma LLC develops therapeutic antibodies and related diagnostic tests for cancer patients and healthcare providers. It develops an obtained in vitro, ex vivo and in vivo proof of concept for its first-in-class fully human monoclonal antibodies that specifically target nucleolin located in the plasma membrane and cytoplasm of tumor cells. The company was founded by Bradford S. Goodwin, Daniel J. Fernandes and Robert L. Capizzi in 2010 and is headquartered in Charleston, SC.
2
| Holding Company | Medical Specialties | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Bradford Goodwin via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | President Director/Board Member Corporate Officer/Principal | |
| ALZA CORPORATION | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Sales & Marketing | |
| PONIARD PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member General Counsel | |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | President Chief Tech/Sci/R&D Officer General Counsel Comptroller/Controller/Auditor Corporate Officer/Principal | |
Avigen, Inc.
 Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Medical Specialties | Director/Board Member Chief Tech/Sci/R&D Officer | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | General Counsel General Counsel Chief Tech/Sci/R&D Officer Director/Board Member President | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Director/Board Member | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Founder Director/Board Member Chief Tech/Sci/R&D Officer General Counsel | |
| INTERMUNE INC | Biotechnology | Corporate Officer/Principal Director/Board Member Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer Comptroller/Controller/Auditor Corporate Officer/Principal Corporate Officer/Principal | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Biotechnology | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Director/Board Member Chairman Director of Finance/CFO | |
Trellis Bioscience, Inc.
 Trellis Bioscience, Inc. BiotechnologyHealth Technology Trellis Bioscience, Inc. is discovers and develops novel human antibody therapeutics. It provides the discovery and development of therapeutic antibodies from human B cells. The firm develops the CellSpot antibody discovery platform, which enables the identification of antibodies directly from human blood. The company was founded by Lawrence Kauvar and Stote Ellsworth in 1998 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Chief Operating Officer | |
| HUMANIGEN, INC. | Biotechnology | Chief Executive Officer Chairman Director/Board Member Comptroller/Controller/Auditor | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman Director/Board Member | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Compliance Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| Stanford University | College/University | Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
| AFFYMAX, INC. | Biotechnology | Director of Finance/CFO Director/Board Member Chief Executive Officer | |
| Massachusetts Institute of Technology | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree Graduate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Masters Business Admin Masters Business Admin Graduate Degree | |
| The Johns Hopkins University | College/University | Doctorate Degree Undergraduate Degree | |
| The Pennsylvania State University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree Corporate Officer/Principal Undergraduate Degree Graduate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| University of California, Davis | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| University of California, Santa Barbara | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| University of Michigan | College/University | Graduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| Haas School of Business | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| TRAVERE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member | |
Amphivena Therapeutics, Inc.
 Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | Drugstore Chains | Director/Board Member Chief Executive Officer Director/Board Member | |
| JASPER THERAPEUTICS, INC. | Financial Conglomerates | Director of Finance/CFO Chief Executive Officer Director/Board Member | |
| Stanford University School of Medicine | College/University | Director/Board Member Doctorate Degree Corporate Officer/Principal | |
Rinat Neuroscience Corp.
 Rinat Neuroscience Corp. BiotechnologyHealth Technology Rinat Neuroscience Corp. manufactures and markets drugs for treating neurological diseases. The company was founded by Arnon Rosenthal and Patrick G. Lynn on November 21, 2000 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Investment Managers | Private Equity Investor Private Equity Investor | |
| AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman |
Statistics
International
| United States | 50 |
| Switzerland | 2 |
Sectoral
| Health Technology | 33 |
| Consumer Services | 13 |
| Finance | 4 |
| Commercial Services | 3 |
| Retail Trade | 2 |
Operational
| Director/Board Member | 555 |
| Corporate Officer/Principal | 235 |
| Independent Dir/Board Member | 139 |
| Chairman | 134 |
| Chief Executive Officer | 107 |
Most connected contacts
| Insiders | |
|---|---|
| Robert Nelsen | 80 |
| Michael Powell | 48 |
| Michael Ross | 44 |
| Jon Saxe | 43 |
| John P. Walker | 39 |
| Mark McDade | 35 |
| Kurt von Emster | 34 |
| Nicholas Simon | 33 |
| Karoly Nikolich | 30 |
| Lori Kunkel | 27 |
| Faheem Hasnain | 27 |
| Leonard Patrick Gage | 26 |
| G. Kirk Raab | 26 |
| Yi Hsiung Chen | 24 |
| Jean-Jacques Bienaimé | 21 |
- Stock Market
- Insiders
- Bradford Goodwin
- Company connections
